Semaglutide and Tirzepatide Weight Loss
Lose Up to 25% of Your Starting Weight
achieve stunning weight loss results with breakthrough Semaglutide and Tirzepatide weekly
weight loss injections: Ozempic, Wegovy, Mounjaro, and now the newly FDA released Zepbound.
With these weekly injections, 86% of patients lost 15% or more of their starting weight.
These FDA approved medications commonly produce more than 25% weight loss from baseline, something that used to only be possible with bariatric surgery. Dr. Lipman’s Telemedicine WeightLoss Center now prescribes Semaglutides-Wegovy, Zepbound, Mounjaro and Ozempic for weight loss. Schedule an appointment with Dr. Lipman today for a telemedicine visit or in person visit to his Miami, Fl office.